Trial intelligence / Profile preview

Post-operative Constipation

ACTRN12623000330640Phase 4Recruiting

Sponsor
The Royal Women's Hospital
Start
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of lactitol in postoperative constipation (2 arms), sponsored by The Royal Women's Hospital. Primary endpoint: Rate of post-operative constipation in the week following surgery. Started Jun 2023; status: recruiting.

02

Drugs

lactitol
03

Conditions

postoperative constipation

Beyond the preview

Go deeper on ACTRN12623000330640.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12623000330640.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call